Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
ID: 355533Type: Posted
Overview

Buyer

Agency for Health Care Research and Quality (HHS-AHRQ)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Agency for Healthcare Research and Quality (AHRQ) has announced a Notice of Funding Opportunity (NOFO) titled "Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)." This initiative invites applications for research projects that test promising digital healthcare interventions aimed at enhancing the quality of healthcare delivery at the point of care, with a focus on health equity, patient experiences, and decision support systems. The funding will be provided through the Phased Innovation Award mechanism, allowing for up to two years of initial development (R21) and up to three years of expanded research (R33), with budgets capped at $280,000 for R21 and $720,000 for R33. Interested applicants should note that the application deadline is July 31, 2026, and can reach out to AHRQ via email at Grant_Queries@ahrq.hhs.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    It appears that you haven't provided any text for me to summarize. Please share the document or text you would like me to condense.
    The Department of Health and Human Services has issued a Notice of Funding Opportunity (NOFO) through the Agency for Healthcare Research and Quality (AHRQ) to support research on innovative digital healthcare solutions aimed at enhancing the quality of healthcare delivery at the point of care. The Phased Innovation Award (R21/R33) mechanism will provide funding over a maximum of five years, split into two phases: up to two years for initial development (R21) and up to three years for expanded research (R33), contingent upon progress made in the initial phase. The initiative encourages proposals that test digital interventions, such as artificial intelligence and patient-centered technologies, with specific focus areas including health equity, patient experiences, and decision support systems. Application deadlines commence October 16, 2024, with budgets capped at $280,000 for the R21 phase and $720,000 for the R33 phase. The emphasis is on collecting evidence to facilitate effective integration and sustainability of these technologies into clinical workflows, ultimately improving healthcare outcomes and reducing disparities among various populations. The AHRQ prioritizes research addressing underserved communities in alignment with national health objectives.
    Similar Opportunities
    Loading similar opportunities...